vs
凯特制药（NAMS）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是凯特制药的1.7倍（$32.3M vs $19.1M），RBB Bancorp净利率更高（31.5% vs -90.7%，领先122.2%），凯特制药同比增速更快（740.1% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-37.8M）
凯特制药是一家美国生物技术企业，专注于研发癌症免疫治疗产品，核心方向为基因工程改造的自体嵌合抗原受体T细胞（CAR-T）疗法，这是一种基于嵌合抗原受体与T细胞的细胞治疗技术。公司成立于2009年，总部位于加利福尼亚州圣莫尼卡，2017年被吉利德科学收购。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
NAMS vs RBB — 直观对比
营收规模更大
RBB
是对方的1.7倍
$19.1M
营收增速更快
NAMS
高出727.5%
12.6%
净利率更高
RBB
高出122.2%
-90.7%
自由现金流更多
RBB
多$80.3M
$-37.8M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.1M | $32.3M |
| 净利润 | $-17.4M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -186.1% | 39.5% |
| 净利率 | -90.7% | 31.5% |
| 营收同比 | 740.1% | 12.6% |
| 净利润同比 | 55.5% | 132.1% |
| 每股收益（稀释后） | $-0.15 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAMSRBB
| Q4 25 | — | $32.3M | ||
| Q3 25 | — | $32.6M | ||
| Q2 25 | $19.1M | $35.8M | ||
| Q1 25 | — | $28.5M | ||
| Q4 24 | $12.8M | $28.7M | ||
| Q3 24 | $29.1M | $30.3M | ||
| Q2 24 | — | $27.5M | ||
| Q1 24 | — | $28.2M |
净利润NAMSRBB
| Q4 25 | — | $10.2M | ||
| Q3 25 | — | $10.1M | ||
| Q2 25 | $-17.4M | $9.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | $-92.2M | $4.4M | ||
| Q3 24 | $-16.6M | $7.0M | ||
| Q2 24 | — | $7.2M | ||
| Q1 24 | — | $8.0M |
营业利润率NAMSRBB
| Q4 25 | — | 39.5% | ||
| Q3 25 | — | 40.7% | ||
| Q2 25 | -186.1% | 36.1% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | -338.5% | 17.6% | ||
| Q3 24 | -85.9% | 31.6% | ||
| Q2 24 | — | 35.6% | ||
| Q1 24 | — | 39.9% |
净利率NAMSRBB
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 31.2% | ||
| Q2 25 | -90.7% | 26.1% | ||
| Q1 25 | — | 8.0% | ||
| Q4 24 | -721.7% | 15.3% | ||
| Q3 24 | -57.2% | 23.1% | ||
| Q2 24 | — | 26.4% | ||
| Q1 24 | — | 28.4% |
每股收益（稀释后）NAMSRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | — | $0.59 | ||
| Q2 25 | $-0.15 | $0.52 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | $-0.91 | $0.26 | ||
| Q3 24 | $-0.18 | $0.39 | ||
| Q2 24 | — | $0.39 | ||
| Q1 24 | — | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $739.2M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $778.5M | $523.4M |
| 总资产 | $815.1M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资NAMSRBB
| Q4 25 | — | $212.3M | ||
| Q3 25 | — | $234.9M | ||
| Q2 25 | $739.2M | $191.9M | ||
| Q1 25 | — | $238.8M | ||
| Q4 24 | $834.2M | $257.7M | ||
| Q3 24 | $422.7M | $349.4M | ||
| Q2 24 | — | $252.8M | ||
| Q1 24 | — | — |
总债务NAMSRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益NAMSRBB
| Q4 25 | — | $523.4M | ||
| Q3 25 | — | $514.3M | ||
| Q2 25 | $778.5M | $517.7M | ||
| Q1 25 | — | $510.3M | ||
| Q4 24 | $757.5M | $507.9M | ||
| Q3 24 | $378.9M | $509.7M | ||
| Q2 24 | — | $511.3M | ||
| Q1 24 | — | $514.0M |
总资产NAMSRBB
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | $815.1M | $4.1B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | $864.6M | $4.0B | ||
| Q3 24 | $439.2M | $4.0B | ||
| Q2 24 | — | $3.9B | ||
| Q1 24 | — | $3.9B |
负债/权益比NAMSRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.7M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-37.8M | $42.6M |
| 自由现金流率自由现金流/营收 | -197.2% | 131.8% |
| 资本支出强度资本支出/营收 | 0.5% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-119.7M | $73.5M |
8季度趋势，按日历期对齐
经营现金流NAMSRBB
| Q4 25 | — | $43.4M | ||
| Q3 25 | — | $2.1M | ||
| Q2 25 | $-37.7M | $21.7M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | $-37.5M | $58.5M | ||
| Q3 24 | $-12.5M | $24.5M | ||
| Q2 24 | — | $11.7M | ||
| Q1 24 | — | $4.8M |
自由现金流NAMSRBB
| Q4 25 | — | $42.6M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | $-37.8M | $21.6M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | $-37.5M | $57.7M | ||
| Q3 24 | $-12.6M | $24.2M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | — | $4.7M |
自由现金流率NAMSRBB
| Q4 25 | — | 131.8% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | -197.2% | 60.2% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | -293.5% | 201.0% | ||
| Q3 24 | -43.2% | 80.0% | ||
| Q2 24 | — | 42.0% | ||
| Q1 24 | — | 16.6% |
资本支出强度NAMSRBB
| Q4 25 | — | 2.5% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | 0.5% | 0.3% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.0% | 2.7% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.5% |
现金转化率NAMSRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
